retatrutide triple agonist glp-1 gip glucagon phase 2 results trial obesity First-in-Class 'Triple-G'! Retatrutide, a first-in Eli Lilly: GLP-1R/GCGR/GIPR Triagonist Reduces
Pay in 4 interest-free payments of $6.74 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 7 - Oct 12
























